GSDMD-dependent IL-1 signaling in intestinal inflammation
肠道炎症中 GSDMD 依赖性 IL-1 信号传导
基本信息
- 批准号:10024455
- 负责人:
- 金额:$ 54.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-24 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAttenuatedAutomobile DrivingBinding ProteinsBiochemicalBiochemistryBiological AssayBiopsyCASP1 geneCASP8 geneCDC37 geneCDC37 homolog proteinCell physiologyCellsCellular StructuresChronicColitisColonComplementComplexCrohn&aposs diseaseDataDiseaseElectron MicroscopyEpithelial CellsEtiologyEventExtracellular SpaceFamily memberFinancial compensationGenetic PolymorphismHelper-Inducer T-LymphocyteIL1R1 geneImmuneIn VitroInflammasomeInflammationInflammatoryInflammatory Bowel DiseasesInterleukin-1Interleukin-1 betaIntestinal SecretionsIntestinesKnowledgeLengthLipid BindingLiteratureMapsMediatingModelingMolecularMolecular ChaperonesMusMutationMyeloid CellsNonlyticPathogenesisPathogenicityPathway interactionsPatientsPeptide Signal SequencesPolyubiquitinationPredispositionPreventive measureProcessProductionProteinsProteomicsRegulationRoleSecretory VesiclesSignal TransductionSodium Dextran SulfateSourceStimulusStructureT-LymphocyteTCR ActivationTestingTissuesUbiquitinationUlcerative ColitisUnited StatesVesicleanakinrabasecell typecytokinedesigndextran sulfate sodium induced colitiseffective therapyextracellular vesiclesin vivoinflammatory disease of the intestineinsightintestinal epitheliummouse modelnovelnovel therapeuticsprogramspublic health relevancerapid growthreceptorrecruitresponsetargeted treatmenttherapeutic targetubiquitin-protein ligasevesicular release
项目摘要
Abstract:
About 1.3 million people suffer from IBD (chronic inflammation of the intestine) in the United States. The etiology
of IBD remains elusive and preventive measures or a cure are not available. Inflammasomes and derived
cytokines IL-1β are being intensely investigated as the signaling hub that is dys-regulated in inflammatory bowel
disease (IBD). IL-1β is synthesized as inactive pro-forms with no secretory signal sequence. Recent studies
have found that a lipid binding protein, Gasdermin D (GSDMD), is required for release of IL-1β in response to
caspase-1/11 inflammasome activation. This breakthrough led to a rapid growth of literature that focuses on the
pore forming and associated pyroptotic activity of GSDMD in myeloid cells. Interestingly, we discovered a novel
nonpyrototic role of GSDMD in guiding the release of IL-1β containing vesicles from intestinal epithelia cells and
T cells in response to Caspase 8 (Casp8) but not casp1 activation. Through unbiased proteomic analysis, we
identified a set of novel GSDMD-interacting proteins in intestinal epithelial cells (IECs), including NEDD4 (an E3
ligase) and the Hsp90 co-chaperone CDC37. Ablation of GSDMD or NEDD4 abolished LPS and ATP-induced
IL-1β production from IECs. Strikingly, LPS+ATP stimulation led to the polyubiquitination of pro-IL-1β, which was
secreted and processed into mature IL-1β along with a complex containing full-length GSDMD, Hsp90/CDC37,
NEDD4, Atg7, Casp8 but not Casp1. In vitro ubiquitination assay demonstrated that NEDD4, known to interact
with LC3 and promote cargo loading into secretory vesicles, catalyzed the polyubiquitination of pro-IL-1β. Indeed,
while GSDMD was associated with LC3+ vesicles; GSDMD-dependent release of extracellular vesicles (< 200
nm) were detected by electron microscopy, which contains the GSDMD/NEDD4/IL-1β complex. Moreover,
inactivating mutation in the Asp276 of GSDMD, which abolishes its pore-forming and pyroptotic activity, did not
impact the GSDMD-guided IL-1β secretion from IECs. In TH17 cells, a T helper cell subset highly relevant to
intestinal inflammation, this GSDMD-guided secretion of polyubiquitinated pro-IL-1β complex (GSDMD, Hsp90,
Casp8 and NEDD4) was also readily detected in response to ATP stimulation and TCR activation. Collectively,
the data revealed a novel nonpyroptotic role for GSDMD in IL-1β release from non-myeloid cells. The pathogenic
role of the GSDMD-guided IL-1β release was investigated in two mouse models of intestinal inflammation. Firstly,
while polyubiquitinated pro-IL-1β, mIL-1β and the GSDMD/NEDD4-secretary complex were induced in a
GSDMD-dependent manner in the intestinal explants in response to dextran sodium sulfate (DSS)-induce colitis,
GSDMD-deficiency attenuated the intestinal inflammation. Secondly, GSDMD or IL-1β deficiency in naïve T cells
reduced their ability to elicit intestinal inflammation. Based on these findings, we hypothesize that the GSDMD
mediates distinct pathways (guided secretion and pyroptosis) for IL-1β release in non-myeloid and myeloid cells,
which jointly contribute to the pathogenesis of intestinal inflammation in a coordinated manner. We will test this
hypothesis through the following aims: (1) Investigate the molecular mechanism for GSDMD-guided secretory
pathway for IL-1β release; (2) Investigate the cell-type and pathway-specific role of GSDMD-IL-1β axis in
intestinal inflammation, including GSDMD-mediated pyroptotic versus GSDMD-guided IL-1β secretion on the
intestinal inflammation.
抽象的:
在美国,大约有130万人患有IBD(肠道慢性感染)。病因
IBD仍然难以捉摸,预防措施或治疗不可用。炎症并得出
细胞因子IL-1β正在积极研究为炎症肠中调节的信号枢纽
疾病(IBD)。 IL-1β被合成为无秘书信号序列的非活性促成形式。最近的研究
已经发现,释放IL-1β的脂质结合蛋白Gasdermin d(GSDMD)响应于
caspase-1/11炎性体激活。这一突破导致文学的迅速增长,重点是
GSDMD在髓样细胞中的孔形成和相关的凋亡活性。有趣的是,我们发现了一本小说
GSDMD在指导含肠上皮细胞和含有IL-1β的蔬菜的非流动性作用
T细胞响应caspase 8(CASP8)而不是CASP1激活。通过公正的蛋白质组学分析,我们
确定了一组新型的GSDMD相互作用蛋白在肠上皮细胞(IEC)中,包括NEDD4(E3
连接酶)和HSP90副酮CDC37。 GSDMD或NEDD4消除了LPS和ATP诱导的
IEC的IL-1β产生。令人惊讶的是,LPS+ATP刺激导致了Pro-IL-1β的多泛素化,这是
分泌并加工成成熟的IL-1β,以及包含全长GSDMD的复合物,HSP90/CDC37,
NEDD4,ATG7,CASP8,但不是CASP1。体外泛素化测定法证明了NEDD4,已知可以相互作用
使用LC3并促进货物加载到秘密蔬菜中,催化了Pro-IL-1β的多泛素化。的确,
GSDMD与LC3+蔬菜有关; GSDMD依赖性细胞外蔬菜的释放(<200
通过含有GSDMD/NEDD4/IL-1β复合物的电子显微镜检测到NM)。而且,
GSDMD的ASP276中的灭活突变,废除了其孔形成和凋亡活性
影响IEC的GSDMD引导的IL-1β分泌。在Th17细胞中,T辅助细胞子集与
肠炎,这种GSDMD引导的多泛素化pro-IL-1β复合物的分泌(GSDMD,HSP90,
还响应ATP刺激和TCR激活而容易检测到CASP8和NEDD4)。共同
该数据揭示了GSDMD在非乳突细胞中释放IL-1β中的新型非凋亡作用。致病性
在两种小鼠注射小鼠模型中,研究了GSDMD引导的IL-1β释放的作用。首先,
虽然在A中诱导了多泛素化的Pro-IL-1β,MIL-1β和GSDMD/NEDD4秘书络合物
肠外植物中的GSDMD依赖性方式响应硫酸葡萄糖钠(DSS)诱导的结肠炎,
GSDMD缺陷减弱了肠道注射。其次,幼稚的T细胞中的GSDMD或IL-1β缺乏症
降低了他们引起肠道炎症的能力。基于这些发现,我们假设GSDMD
介导非肌动物和髓样细胞中的IL-1β释放的不同途径(引导秘密和凋亡),
这共同以协调的方式共同导致肠道炎症的发病机理。我们将测试这个
通过以下目的假设:(1)研究GSDMD引导分泌的分子机制
IL-1β释放的途径; (2)研究GSDMD-IL-1β轴在细胞类型和途径特异性的作用
肠炎,包括GSDMD介导的凋亡与GSDMD引导的IL-1β分泌
肠炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaoxia Li其他文献
Xiaoxia Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaoxia Li', 18)}}的其他基金
IL-17-driven mechanisms for tumor progression and resistance to therapies
IL-17 驱动的肿瘤进展和治疗耐药机制
- 批准号:
10493940 - 财政年份:2022
- 资助金额:
$ 54.17万 - 项目类别:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
TRAF4 E3 连接酶在 IL-25 介导的过敏性哮喘中的作用
- 批准号:
10112955 - 财政年份:2020
- 资助金额:
$ 54.17万 - 项目类别:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
TRAF4 E3 连接酶在 IL-25 介导的过敏性哮喘中的作用
- 批准号:
9885028 - 财政年份:2020
- 资助金额:
$ 54.17万 - 项目类别:
Myeloid cells, aging and the metabolic syndrome
骨髓细胞、衰老和代谢综合征
- 批准号:
8702069 - 财政年份:2013
- 资助金额:
$ 54.17万 - 项目类别:
Myeloid cells, aging and the metabolic syndrome
骨髓细胞、衰老和代谢综合征
- 批准号:
8611557 - 财政年份:2013
- 资助金额:
$ 54.17万 - 项目类别:
Molecular mechanisms of IL-1R-TLR mediated signaling
IL-1R-TLR介导信号传导的分子机制
- 批准号:
8242732 - 财政年份:2011
- 资助金额:
$ 54.17万 - 项目类别:
Molecular and Cellular Mechanisms of IL-17 Signaling
IL-17 信号传导的分子和细胞机制
- 批准号:
8453438 - 财政年份:2011
- 资助金额:
$ 54.17万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
识别和靶向非小细胞肺癌化疗引起的免疫治疗耐药的新机制
- 批准号:
10657188 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
通过调节肿瘤炎症提高胶质瘤免疫治疗效果
- 批准号:
10750788 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Microvascular Neuroimaging in Age-related Alzheimer's Disease and Tauopathies
年龄相关性阿尔茨海默病和 Tau蛋白病的微血管神经影像学
- 批准号:
10738372 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别:
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
定义 CNPY2 通过巨噬细胞介导促进肿瘤进展的作用。
- 批准号:
10657859 - 财政年份:2023
- 资助金额:
$ 54.17万 - 项目类别: